Cormorant Asset Management
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 Clarendon St Fl 52, Boston, Massachu...Phone Number
(857) 702-0388Website
www.cormorant-asset.comRevenue
<$5 MillionIndustry
About Cormorant Asset Management
Cormorant Asset Management Org Chart
Is Cormorant Asset Management your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cormorant Asset Management has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cormorant Asset Management launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cormorant Asset Management is spiking on competitors!
Cormorant Asset Management, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cormorant Asset Management had a recent Job posting/layoffs
Earning: See what the market has to say on Cormorant Asset Management recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cormorant Asset Management
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cormorant Asset Management has new funding data
Recommended Actions
Find VP level buyers at Cormorant Asset Management
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cormorant Asset Management is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Cormorant Asset Management is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Cormorant Asset Management.
Most Recent Scoops
Cormorant Asset Management News & Media
Neurona Therapeutics Raises $120M in Funding
Neurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors, including The Column Group, LYFE Capital, Schroders Capital, Willett Advisors, Ysios Capital Partners, Euclidean Capital, SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund, Sphera […] The post Neurona Therapeutics Raises $120M in Funding appeaCormorant Asset Management, LP Acquires New Stake in Frequency Therapeutics Inc
Cormorant Asset Management, LP (Trades, Portfolio), a notable investment firm, has recently expanded its portfolio by purchasing shares in Frequency Therapeutics Inc (NASDAQ:FREQ). The transaction, which took place on November 6, 2023, saw Cormorant Asset Management acquiring 679,170 shares at a price of $0.2996 per share. The firm now holds an 8.49% stake in Frequency Therapeutics, indicating a significant level of confidence in the biotechnology company's prospects.Cormorant Asset Management, LP Acquires New Stake in VYNE Therapeutics Inc
On November 1, 2023, Cormorant Asset Management, LP (Trades, Portfolio) made a significant move in the biopharmaceutical sector by acquiring 1,394,336 shares of VYNE Therapeutics Inc (NASDAQ:VYNE). Cormorant Asset Management, LP (Trades, Portfolio), based in Boston, MA, is a well-recognized investment firm with a focus on the healthcare sector.Atreca Scoops Up $125M
REDWOOD CITY, CA, Atreca announced today the closing of an oversubscribed $125 million financing.
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cormorant Asset Management
Founded in 2013, Cormorant Asset Management ('Cormorant') is a prominent life sciences investment firm with over $3B of assets under management as of June 2021. Cormorant is driven by a deep focus on fundamental scientific principles and provides financial resources to support the most innovative and promising publicly traded and private companies... Read More